|

SGC001 Clinical Trials

1 actively recruiting trial

No change since June 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Beijing Sungen Biomedical Technology Co., Ltd1

Indications

  • Acute Anterior ST-Segment Elevation Myocardial Infarction1
  • Anterior Myocardial Infarction1
  • Heart Disease1

Other1 trial

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.